Thursday, 8 October 2026
Venture Intelligence News

Private Equity PE-VC Fund Investments

Aragen Life Sciences attracts Rs.300-Cr from Avendus Future Leaders Fund, SBI Life

Source Mint (opens in a new tab)

Aragen Life Sciences (formerly GVK Biosciences), a Hyderabad-based contract research, development, and manufacturing organisation (CRDMO), has attracted INR 300 crore (in equal share) from Avendus Future Leaders Fund III and SBI Life Insurance in return for a minority stake of over 2.5%. The stake has been acquired through a secondary transaction from the Reddy Investment Trust, which is associated with the GVK Group.

Company website ↗ (opens in a new tab)

Between Nov 2007 and Jan 2025, Aragen Life Sciences had raised about USD 497 M from Quadria, Goldman Sachs, ChrysCapital and Peak XV Partners.